Article Versions Notes

Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci E-A, et al. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. Cancers. 2021; 13(7):1565. https://doi.org/10.3390/cancers13071565

Banys-Paluchowski, Maggie, Maria Luisa Gasparri, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, Steffi Hartmann, Marc Thill, Isabel T. Rubio, Rosa Di Micco, Eduard-Alexandru Bonci, and et al. 2021. "Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study" Cancers 13, no. 7: 1565. https://doi.org/10.3390/cancers13071565

Banys-Paluchowski, M., Gasparri, M. L., de Boniface, J., Gentilini, O., Stickeler, E., Hartmann, S., Thill, M., Rubio, I. T., Di Micco, R., Bonci, E.-A., Niinikoski, L., Kontos, M., Karadeniz Cakmak, G., Hauptmann, M., Peintinger, F., Pinto, D., Matrai, Z., Murawa, D., Kadayaprath, G., ... the AXSANA Study Group. (2021). Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study. Cancers, 13(7), 1565. https://doi.org/10.3390/cancers13071565